These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2204520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K, Gregorová I, Vancura J, Silinková-Málková E, Hradec E.
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [Abstract] [Full Text] [Related]

  • 3. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A, Postuła M, Cybulska I, Dobrucki T, Kabat M, Peczkowska M, Janas J, Janaszek-Sitkowska H, Makowiecka-Cieśla M, Januszkiewicz A.
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
    Wu VC, Kuo CC, Chang HW, Tsai CT, Lin CY, Lin LY, Lin YH, Wang SM, Huang KH, Fang CC, Ho YL, Liu KL, Chang CC, Chueh SC, Lin SL, Yen RF, Wu KD, TAIPAI study group.
    Clin Chim Acta; 2010 May 02; 411(9-10):657-63. PubMed ID: 20117105
    [Abstract] [Full Text] [Related]

  • 5. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM, Ayers CR, Vaughan ED, Peach MJ, Herf SM.
    J Clin Invest; 1979 Apr 02; 63(4):718-26. PubMed ID: 438332
    [Abstract] [Full Text] [Related]

  • 6. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F, Mattarello MJ, Albiger NM.
    Exp Clin Endocrinol Diabetes; 2007 Mar 02; 115(3):171-4. PubMed ID: 17427105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M.
    J Hypertens; 2007 Jan 02; 25(1):177-86. PubMed ID: 17143190
    [Abstract] [Full Text] [Related]

  • 9. Single dose captopril as a diagnostic test for primary aldosteronism.
    Lyons DF, Kem DC, Brown RD, Hanson CS, Carollo ML.
    J Clin Endocrinol Metab; 1983 Nov 02; 57(5):892-6. PubMed ID: 6352726
    [Abstract] [Full Text] [Related]

  • 10. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
    Mantero F, Fallo F, Opocher G, Armanini D, Boscaro M, Scaroni C.
    Clin Sci (Lond); 1981 Dec 02; 61 Suppl 7():289s-293s. PubMed ID: 7032817
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C, Sánchez G, Boyer JL, Delmar M, Serrano PA.
    Arch Inst Cardiol Mex; 1982 Dec 02; 52(4):295-300. PubMed ID: 6291470
    [Abstract] [Full Text] [Related]

  • 13. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan 02; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of surgical and conservative treatment of patients with primary aldosteronism.
    Horký K, Widimský J, Hradec E, Gregorová I, Hradec M.
    Exp Clin Endocrinol; 1987 Dec 02; 90(3):337-46. PubMed ID: 3450533
    [Abstract] [Full Text] [Related]

  • 15. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T, Doi K, Ogihara T, Ichihara K, Hata T, Kumahara Y.
    Prog Biochem Pharmacol; 1976 Dec 02; 12():174-89. PubMed ID: 1019163
    [Abstract] [Full Text] [Related]

  • 16. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Semplicini A, Agabiti-Rosei E, Pessina AC, Mantero F, PAPY Study Investigators.
    J Hypertens; 2007 Jul 02; 25(7):1433-42. PubMed ID: 17563566
    [Abstract] [Full Text] [Related]

  • 17. Primary aldosteronism: renaissance of a syndrome.
    Young WF.
    Clin Endocrinol (Oxf); 2007 May 02; 66(5):607-18. PubMed ID: 17492946
    [Abstract] [Full Text] [Related]

  • 18. [New potentialities in the treatment of idiopathic hyperaldosteronism].
    Podzolkov VI, Rodionov AV.
    Klin Med (Mosk); 2004 May 02; 82(6):34-8. PubMed ID: 15344688
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z, Widimský J, Rosa J, Wichterle D, Strauch B, Petrák O, Zelinka T, Vlková J, Masek M, Dvoráková J, Holaj R.
    J Hum Hypertens; 2010 Oct 02; 24(10):625-30. PubMed ID: 20574447
    [Abstract] [Full Text] [Related]

  • 20. [The long-term administration of dexamethasone for the differentiation of the 4 types of hyperaldosteronism].
    Watanabe Y, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1995 Mar 20; 71(2):149-66. PubMed ID: 7750627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.